CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Journal of the American Heart Association · 18.06.2024 · 13 (12)
DOI: 10.1161/jaha.123.033791 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 18.06.2024. Verfasst von Kayla R Tunehag und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA. Hauptthemen laut MEDLINE: Black or African American, Clopidogrel, Cytochrome P-450 CYP2C19, Hemorrhage. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background Cytochrome P450 2C19 (CYP2C19) intermediate and poor metabolizer patients exhibit diminished clopidogrel clinical effectiveness after percutaneous coronary intervention (PCI). However, outcome studies to date have lacked racial diversity. Thus, the impact of CYP2C19 genotype on cardiovascular outcomes in patients treated with clopidogrel who identify as Black or African American remains unclear. Methods and Results Adults among 5 institutions who self‐identified as Black or African American, underwent PCI and clinical CYP2C19 genotyping, and were treated with clopidogrel were included. Data were abstracted from health records. Major atherothrombotic (composite of death, myocardial infarction, ischemic stroke, stent thrombosis, or revascularization for unstable angina) and bleeding event rates within 1 year after PCI were compared across CYP2C19 metabolizer groups using multivariable Cox regression adjusted for potential confounders and baseline variables meeting a threshold of P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA.
- Department of Pharmacotherapy & Translational Research and Center for Pharmacogenomics and Precision Medicine College of Pharmacy, University of Florida Gainesville FL USA.
- Division of Cardiology, Department of Medicine College of Medicine-Jacksonville, University of Florida Jacksonville FL USA.
- Division of Cardiology and McAllister Heart Institute, School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA.
- Division of Cardiovascular Medicine College of Medicine, University of Florida Gainesville FL USA.
- University of Maryland School of Medicine Department of Medicine and Program for Personalized and Genomic Medicine Baltimore MD USA.
ORCID-Profile: Kayla R Tunehag, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Caitrin W McDonough, Luis Ortega-Paz, Yehua Wang, Almut G Winterstein, Dominick J Angiolillo, Larisa H Cavallari, Craig R Lee
Förderung
- NHGRI NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Tunehag, K. R., Thomas, C. D., Franchi, F., Rossi, J. S., Keeley, E. C., Anderson, R. D., Beitelshees, A. L., Duarte, J. D., Gong, Y., Kerensky, R. A., McDonough, C. W., Nguyen, A. B., Ortega-Paz, L., Venkatesh, S., Wang, Y., Johnson, J. A., Winterstein, A. G., Stouffer, G. A., Angiolillo, D. J., …, & Lee, C. R. (2024). CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association, 13(12). https://doi.org/10.1161/jaha.123.033791
Vancouver
Tunehag KR, Thomas CD, Franchi F, Rossi JS, Keeley EC, Anderson RD, et al. CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association. 2024;13(12). doi:10.1161/jaha.123.033791
BibTeX
@article{Tunehag2024,
author = {Tunehag, Kayla R and Thomas, Cameron D and Franchi, Francesco and Rossi, Joseph S and Keeley, Ellen C and Anderson, R David and Beitelshees, Amber L and Duarte, Julio D and Gong, Yan and Kerensky, Richard A and McDonough, Caitrin W and Nguyen, Anh B and Ortega-Paz, Luis and Venkatesh, Sanjay and Wang, Yehua and Johnson, Julie A and Winterstein, Almut G and Stouffer, George A and Angiolillo, Dominick J and Cavallari, Larisa H and Lee, Craig R},
title = {CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {12},
doi = {10.1161/jaha.123.033791}
}
EUVIMED